Northern Trust Corp Vir Biotechnology, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 878,924 shares of VIR stock, worth $6.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

878,924

Previous 833,491 5.45%

Holding current value

$6.5 Million

Previous $7.42 Million 11.26%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.26 - $10.7 $329,843 - $486,133	45,433 Added 5.45%	878,924 $6.58 Million
Q2 2024 Aug 14, 2024	SELL	$7.63 - $12.66 $191,513 - $317,766	-25,100 Reduced 2.92%	833,491 $7.42 Million
Q1 2024 May 14, 2024	SELL	$8.6 - $11.9 $676,931 - $936,684	-78,713 Reduced 8.4%	858,591 $8.7 Million
Q4 2023 Feb 13, 2024	SELL	$7.76 - $10.29 $475,292 - $630,252	-61,249 Reduced 6.13%	937,304 $9.43 Million
Q3 2023 Nov 13, 2023	BUY	$9.14 - $24.62 $199,325 - $536,912	21,808 Added 2.23%	998,553 $9.36 Million
Q2 2023 Aug 11, 2023	BUY	$23.2 - $27.29 $2.56 Million - $3.01 Million	110,365 Added 12.74%	976,745 $24 Million
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $1.95 Million - $2.7 Million	87,681 Added 11.26%	866,380 $20.2 Million
Q4 2022 Feb 13, 2023	SELL	$19.96 - $28.22 $1.04 Million - $1.47 Million	-51,965 Reduced 6.26%	778,699 $19.7 Million
Q3 2022 Nov 14, 2022	SELL	$18.26 - $31.1 $433,474 - $738,282	-23,739 Reduced 2.78%	830,664 $16 Million
Q2 2022 Aug 12, 2022	BUY	$19.08 - $26.7 $4.64 Million - $6.49 Million	243,076 Added 39.76%	854,403 $21.8 Million
Q1 2022 May 13, 2022	SELL	$21.19 - $40.01 $173,334 - $327,281	-8,180 Reduced 1.32%	611,327 $15.7 Million
Q4 2021 Feb 08, 2022	SELL	$30.97 - $54.03 $97,307 - $169,762	-3,142 Reduced 0.5%	619,507 $25.9 Million
Q3 2021 Nov 15, 2021	SELL	$34.9 - $54.54 $998,523 - $1.56 Million	-28,611 Reduced 4.39%	622,649 $27.1 Million
Q2 2021 Aug 13, 2021	BUY	$38.75 - $51.0 $1.81 Million - $2.38 Million	46,639 Added 7.71%	651,260 $30.8 Million
Q1 2021 May 12, 2021	SELL	$26.34 - $83.07 $853,205 - $2.69 Million	-32,392 Reduced 5.08%	604,621 $31 Million
Q4 2020 Feb 11, 2021	SELL	$25.51 - $43.38 $454,282 - $772,511	-17,808 Reduced 2.72%	637,013 $17.1 Million
Q3 2020 Nov 16, 2020	BUY	$28.28 - $53.6 $4.64 Million - $8.79 Million	164,032 Added 33.42%	654,821 $22.5 Million
Q2 2020 Aug 14, 2020	BUY	$27.89 - $47.86 $10.6 Million - $18.3 Million	381,561 Added 349.33%	490,789 $20.1 Million
Q1 2020 May 14, 2020	BUY	$12.04 - $60.2 $41,851 - $209,255	3,476 Added 3.29%	109,228 $3.74 Million
Q4 2019 Feb 14, 2020	BUY	$11.83 - $15.85 $1.25 Million - $1.68 Million	105,752 New	105,752 $1.33 Million

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Vir Biotechnology, Inc. Transaction History